Cited by 5,141Research on Leishmaniasis StudiesLeprosy Research and TreatmentBrucella: diagnosis, epidemiology, treatment

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Leishmaniasis Worldwide and Global Estimates of Its Incidence

Open access

Alvar, Jorge, Vélez, Iván D., Bern, Caryn, Herrero, Mercé, Desjeux, Philippe, Cano, Jorge, Jannin, Jean, Boer, Margriet den, the WHO Leishmaniasis Control Team·2012·PLoS ONE

DOI 10.1371/journal.pone.0035671PMC PMC3365071

Open this paper in CoChat — free account Open PDF

Abstract

As part of a World Health Organization-led effort to update the empirical evidence base for the leishmaniases, national experts provided leishmaniasis case data for the last 5 years and information regarding treatment and control in their respective countries and a comprehensive literature review was conducted covering publications on leishmaniasis in 98 countries and three territories (see 'Leishmaniasis Country Profiles Text S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21, S22, S23, S24, S25, S26, S27, S28, S29, S30, S31, S32, S33, S34, S35, S36, S37, S38, S39, S40, S41, S42, S43, S44, S45, S46, S47, S48, S49, S50, S51, S52, S53, S54, S55, S56, S57, S58, S59, S60, S61, S62, S63, S64, S65, S66, S67, S68, S69, S70, S71, S72, S73, S74, S75, S76, S77, S78, S79, S80, S81, S82, S83, S84, S85, S86, S87, S88, S89, S90, S91, S92, S93, S94, S95, S96, S97, S98, S99, S100, S101'). Additional information was collated during meetings conducted at WHO regional level between 2007 and 2011. Two questionnaires regarding epidemiology and drug access were completed by experts and national program managers. Visceral and cutaneous leishmaniasis incidence ranges were estimated by country and epidemiological region based on reported incidence, underreporting rates if available, and the judgment of national and international experts. Based on these estimates, approximately 0.2 to 0.4 cases and 0.7 to 1.2 million VL and CL cases, respectively, occur each year. More than 90% of global VL cases occur in six countries: India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil. Cutaneous leishmaniasis is more widely distributed, with about one-third of cases occurring in each of three epidemiological regions, the Americas, the Mediterranean basin, and western Asia from the Middle East to Central Asia. The ten countries with the highest estimated case counts, Afghanistan, Algeria, Colombia, Brazil, Iran, Syria, Ethiopia, North Sudan, Costa Rica and Peru, together account for 70 to 75% of global estimated CL incidence. Mortality data were extremely sparse and generally represent hospital-based deaths only. Using an overall case-fatality rate of 10%, we reach a tentative estimate of 20,000 to 40,000 leishmaniasis deaths per year. Although the information is very poor in a number of countries, this is the first in-depth exercise to better estimate the real impact of leishmaniasis. These data should help to define control strategies and reinforce leishmaniasis advocacy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0035671

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Untitled work
(1996) · Cited by 6,884
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,636
Leishmaniasis: current situation and new perspectives
Desjeux, P. M. P. (2004) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.03.004 · Cited by 2,329 · cited 1×
“Reported leishmaniasis case figures are widely acknowledged to represent gross underestimates of the true burden, but studies that measure the degree of underreporting are rare [23].”
Background
World Development Report 1993
Bank, W. (1993) · doi:10.1596/0-1952-0890-0 · Cited by 2,213
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis
King, C. H., Dickman, K. R., & Tisch, D. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66457-4 · Cited by 898 · cited 1×
“The accuracy of this measure depends on the reliability of the incidence, duration, severity and mortality data for a given condition, as well as the underlying assumptions used in the calculations [7,14].”
Background
Health metrics and evaluation: strengthening the science
Murray, C. J., & Frenk, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60526-7 · Cited by 849
Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and Malaria
Hotez, P. J., Molyneux, D. H., Fenwick, A., Ottesen, E. A., Sachs, S. E., & Sachs, J. D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030102 · Cited by 822 · cited 1×
“Although estimated to cause the ninth largest disease burden among individual infectious diseases, leishmaniasis is largely ignored in discussions of tropical disease priorities [1,2].”
Background
Leishmaniasis and poverty
Alvar, J., Yactayo, S., & Bern, C. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.09.004 · Cited by 813 · cited 1×
“This consignment to critical oblivion results from its complex epidemiology and ecology, the lack of simple, easily-applied tools for case management and the paucity of current incidence data, and often results in a failure on the part of policy-makers to recognize its importance [3,4].”
Background
Leishmaniasis
Desjeux, P. M. P. (1996) · Clinics in Dermatology · doi:10.1016/0738-081x(96)00057-0 · Cited by 588 · cited 1×
“Visceral leishmaniasis (VL) results in death if not treated, the majority of leishmaniasis deaths go unrecognized, and even with treatment access, VL may result in case-fatality rates of 10–20% [17,18,19,20,21,22].”
Background
Control Of The Leishmaniases
Library, W. (2010) · Cited by 584

Show all 51 references

Research works printed but not linked: 1

AN Maia-Elkhoury, 2007, [Analysis of visceral leishmaniasis reports by the capture-recapture method]., Rev Saude Publica, 41, 931

Sorted by citations

Items 501–600 of 1,004

Antileishmanial activity of essential oil from Chenopodium ambrosioides and its main components against experimental cutaneous leishmaniasis in BALB/c mice
Monzote, L., Pastor, J., Scull, R., & Gille, L. (2014) · Phytomedicine · doi:10.1016/j.phymed.2014.03.002 · Cited by 57
Mucosal leishmaniasis with primary oral involvement: a case series and a review of the literature
Mignogna, M. D., Celentano, A., Leuci, S., Cascone, M., Adamo, D., Ruoppo, E., & Favia, G. (2014) · Oral Diseases · doi:10.1111/odi.12268 · Cited by 57
Investigational drugs for visceral leishmaniasis
Sundar, S., & Chakravarty, J. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.954035 · Cited by 57
Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents – Part III
Ronga, L., Favero, M. D., Cohen, A., Soum, C., Pape, P. L., Savrimoutou, S., Pinaud, N., Mullié, C., Daulouède, S., Vincendeau, P., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.037 · Cited by 57
High levels of anti-Phlebotomus perniciosus saliva antibodies in different vertebrate hosts from the re-emerging leishmaniosis focus in Madrid, Spain
Martín-Martín, I., Molina, R., Rohoušová, I., Drahota, J., Volf, P., & Jiménez, M. (2014) · Veterinary Parasitology · doi:10.1016/j.vetpar.2014.02.045 · Cited by 57
Characterization of Cross-Protection by Genetically Modified Live-Attenuated Leishmania donovani Parasites against Leishmania mexicana
Dey, R., Natarajan, G. K., Bhattacharya, P., Cummings, H., Dagur, P. K., Terrazas, C. A., Selvapandiyan, A., McCoy, J. P., DUNCAN, R. C., Satoskar, A. R., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303145 · Cited by 57
Asteraceae Artemisia campestris and Artemisia herba-alba Essential Oils Trigger Apoptosis and Cell Cycle Arrest in Leishmania infantum Promastigotes
Aloui, Z., Messaoud, C., Haoues, M., Neffati, N., Bassoumi-Jamoussi, I., Essafi‐Benkhadir, K., Boussaïd, M., Guizani, I., & Karoui, H. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/9147096 · Cited by 57
Environmental factors associated with the distribution of visceral leishmaniasis in endemic areas of Bangladesh: modeling the ecological niche
Abdullah, A. Y. M., Dewan, A. M., Shogib, M. R. I., Rahman, M. M., & Hossain, M. F. (2017) · Tropical Medicine and Health · doi:10.1186/s41182-017-0054-9 · Cited by 56
Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical Trial
Mbui, J., Olobo, J. O., Omollo, R., Solomos, A., Kip, A. E., Kirigi, G., Sagaki, P., Kimutai, R., Were, L., Omollo, T., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy747 · Cited by 57
Sterol methyltransferase is required for optimal mitochondrial function and virulence in Leishmania major
Mukherjee, S., Xu, W., Hsu, F., Patel, J., Huang, J., & Zhang, K. (2018) · Molecular Microbiology · doi:10.1111/mmi.14139 · Cited by 56
CD4+ T Cell-Mediated Immunity against the Phagosomal Pathogen Leishmania: Implications for Vaccination
Hohman, L. S., & Peters, N. C. (2019) · Trends in Parasitology · doi:10.1016/j.pt.2019.04.002 · Cited by 57
Recent advances and new strategies in Leishmaniasis diagnosis
de Brito, R. C. F., Aguiar‐Soares, R. D. D. O., Cardoso, J. M. D. O., Coura‐Vital, W., Roatt, B. M., & Reis, A. B. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10846-y · Cited by 56
Global Distribution of Canine Visceral Leishmaniasis and the Role of the Dog in the Epidemiology of the Disease
Boas, D. F. V., Nakasone, E. K. N., Gonçalves, A. A. M., Lair, D. F., de Oliveira, D. S., Pereira, D. F. S., da Silva, G. G., Conrado, I. D. S. S., Resende, L. A., Zaldívar, M. F., et al. (2024) · Pathogens · doi:10.3390/pathogens13060455 · Cited by 67
“On the European continent, euthanasia is generally performed on animals with a serious form of the disease, as a way to prevent prolonged suffering [2,215].”
Background
Lymphocytic Choriomeningitis Virus Expands a Population of NKG2D+CD8+ T Cells That Exacerbates Disease in Mice Coinfected with Leishmania major
Crosby, E. J., Clark, M. L., Novais, F. O., Wherry, E. J., & Scott, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500855 · Cited by 56
Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery
Balaña‐Fouce, R., Álvarez‐Velilla, R., Fernandez‐Prada, C., García‐Estrada, C., & Reguera, R. M. (2014) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2014.07.006 · Cited by 56
Spatial analysis for identification of priority areas for surveillance and control in a visceral leishmaniasis endemic area in Brazil
Barbosa, D. S., Belo, V. S., Rangel, M. E. S., & Werneck, G. L. (2013) · Acta Tropica · doi:10.1016/j.actatropica.2013.12.002 · Cited by 56
Evaluating the Accuracy of Molecular Diagnostic Testing for Canine Visceral Leishmaniasis Using Latent Class Analysis
Solcà, M. D. S., Bastos, L. A., Guedes, C. E. S., Bordoni, M., Borja, L. S., Larangeira, D. F., Tuy, P. G. D. S. E., Amorim, L. D. A. F., Nascimento, E. G., Oliveira, G. G. D. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103635 · Cited by 61
Identifying vaccine targets for anti-leishmanial vaccine development
Sundar, S., & Singh, B. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.894467 · Cited by 58
Leishmania hijacking of the macrophage intracellular compartments
Moal, V. L.-L., & Loiseau, P. M. (2015) · FEBS Journal · doi:10.1111/febs.13601 · Cited by 56
Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase
Pandey, R. K., Kumbhar, B. V., Sundar, S., Kunwar, A., & Prajapati, V. K. (2016) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2016.1171344 · Cited by 56
Canine visceral leishmaniasis in Iran: A systematic review and meta-analysis
Shokri, A., Fakhar, M., & Teshnizi, S. H. (2016) · Acta Tropica · doi:10.1016/j.actatropica.2016.08.020 · Cited by 56
An integrated overview of the midgut bacterial flora composition of Phlebotomus perniciosus, a vector of zoonotic visceral leishmaniasis in the Western Mediterranean Basin
Fraihi, W., Farès, W., Perrin, P., Dorkeld, F., Séréno, D., Barhoumi, W., Sbissi, I., Cherni, S., Chelbi, I., Durvasula, R. V., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005484 · Cited by 56
How will climate change pathways and mitigation options alter incidence of vector-borne diseases? A framework for leishmaniasis in South and Meso-America
Purse, B. V., Masante, D., Golding, N., Pigott, D. M., Day, J. C., Ibáñez‐Bernal, S., Kolb, M., & Jones, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183583 · Cited by 56
Variations in visceral leishmaniasis burden, mortality and the pathway to care within Bihar, India
Jervis, S., Chapman, L. A. C., Dwivedi, S., Karthick, M., Das, A., Rutte, E. A. L., Courtenay, O., Medley, G. F., Banerjee, I., Mahapatra, T., et al. (2017) · Parasites & Vectors · doi:10.1186/s13071-017-2530-9 · Cited by 56
Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression
Bosch‐Nicolau, P., Ubals, M., Salvador, F., Sánchez‐Montalvá, A., Aparicio, G., Erra, A., Salazar, P. M. D., Sulleiro, E., & Molina, I. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007708 · Cited by 56
Assessment of Vaccine-Induced Immunity Against Canine Visceral Leishmaniasis
Moreno, J. (2019) · Frontiers in Veterinary Science · doi:10.3389/fvets.2019.00168 · Cited by 55
Epidemiological and diagnostic aspects of feline leishmaniasis with emphasis on Brazil: a narrative review
Nascimento, L. F. D. J., Cirilo, T. M., Gomes, D. S., Amado-Gomes, A. C., Lima, V. F. S., Scher, R., Jain, S. A., Fujiwara, R. T., & Dolabella, S. S. (2021) · Parasitology Research · doi:10.1007/s00436-021-07372-9 · Cited by 55
An in vitro study of apoptotic like death in Leishmania donovani promastigotes by withanolides
Chandrasekaran, S., Alti, D., Veronica, J., Sundar, S., & Maurya, R. (2013) · Parasitology International · doi:10.1016/j.parint.2013.01.007 · Cited by 55
Exploring the Role of Medicinal Plant-Based Immunomodulators for Effective Therapy of Leishmaniasis
Chouhan, G., Islamuddin, M., Sahal, D., & Afrin, F. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00193 · Cited by 55
Modulation of Innate Immune Mechanisms to Enhance Leishmania Vaccine-Induced Immunity: Role of Coinhibitory Molecules
Gannavaram, S., Bhattacharya, P., Ismail, N., Kaul, A., Singh, R. K., & Nakhasi, H. L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00187 · Cited by 55
Field Evaluation of Two Different Treatment Approaches and Their Ability to Control Fleas and Prevent Canine Leishmaniosis in a Highly Endemic Area
Brianti, E., Napoli, E., Gaglio, G., Falsone, L., Giannetto, S., Basano, F. S., Nazzari, R., Latrofa, M. S., Annoscia, G., Tarallo, V. D., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004987 · Cited by 55
Parasite Biology: The Vectors
Dvořák, V., Shaw, J. J., & Volf, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-72386-0_3 · Cited by 55
The current clinical and geographical situation of cutaneous leishmaniasis based on species identification in Turkey
Özbilgin, A., Töz, S. O., Harman, M., Topal, S. G., Uzun, S., Okudan, F., Güngör, D., Erat, A., Ertabaklar, H., Ertuğ, S., et al. (2018) · Acta Tropica · doi:10.1016/j.actatropica.2018.11.001 · Cited by 55
Toll-Like Receptor and miRNA-let-7e Expression Alter the Inflammatory Response in Leishmania amazonensis-Infected Macrophages
Muxel, S. M., Acuña, S. M., Aoki, J. I., Zampieri, R. A., & Floeter‐Winter, L. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02792 · Cited by 59
Current and promising novel drug candidates against visceral leishmaniasis
Reguera, R. M., Pérez‐Pertejo, Y., Gutiérrez-Corbo, C., Domínguez-Asenjo, B., Ordóñez, C., García‐Estrada, C., Valladares, M. M., & Balaña‐Fouce, R. (2019) · Pure and Applied Chemistry · doi:10.1515/pac-2018-1102 · Cited by 56
Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria
Álvarez-Bardón, M., Pérez‐Pertejo, Y., Ordóñez, C., Sepúlveda‐Crespo, D., Carballeira, N. M., Tekwani, B. L., Murugesan, S., Valladares, M. M., García‐Estrada, C., Reguera, R. M., et al. (2020) · Marine Drugs · doi:10.3390/md18040187 · Cited by 59
The new situation of cutaneous leishmaniasis after Syrian civil war in Gaziantep city, Southeastern region of Turkey
Özkeklikçi, A., Karakuş, M., Özbel, Y., & Töz, S. O. (2016) · Acta Tropica · doi:10.1016/j.actatropica.2016.10.019 · Cited by 54
Mahanine exerts in vitro and in vivo antileishmanial activity by modulation of redox homeostasis
Roy, S., Dutta, D., Satyavarapu, E. M., Yadav, P. K., Mandal, C., Kar, S., & Mandal, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-03943-y · Cited by 54
Neglected zoonotic diseases in Nigeria: role of the public health veterinarian
Elelu, N., Aiyedun, J. O., Mohammed, I. G., Oludairo, O. O., Odetokun, I. A., Mohammed, K. M., Bale, J. O. O., & Nuru, S. (2019) · Pan African Medical Journal · doi:10.11604/pamj.2019.32.36.15659 · Cited by 54
Proteomic analysis of exosomes derived from procyclic and metacyclic-like cultured Leishmania infantum chagasi
Forrest, D. M., Batista, M., Marchini, F. K., Tempone, A. J., & Traub-Csekö, Y. M. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103902 · Cited by 54
First Evidence of Co-Circulation of Emerging Leishmania martiniquensis, Leishmania orientalis, and Crithidia sp. in Culicoides Biting Midges (Diptera: Ceratopogonidae), the Putative Vectors for Autochthonous Transmission in Southern Thailand
Songumpai, N., Promrangsee, C., Noopetch, P., Siriyasatien, P., & Preativatanyou, K. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7110379 · Cited by 54
Vaccine value profile for leishmaniasis
Kaye, P. M., Matlashewski, G., Mohan, S., Rutte, E. A. L., Mondal, D., Khamesipour, A., & Malvolti, S. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.01.057 · Cited by 54
Development and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis
Vallur, A. C., Tutterrow, Y. L., Mohamath, R., Pattabhi, S., Hailu, A., Abdoun, A., Ahmed, A. E., Mukhtar, M. M., Salam, M. A., Almeida, M. L., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1125-3 · Cited by 54
Molecular typing of Leishmania infantum isolates from a leishmaniasis outbreak in Madrid, Spain, 2009 to 2012
Chicharro, C., Llanes-Acevedo, I. P., García, E. B., Nieto, J., Moreno, J., & Cruz, I. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.30.20545 · Cited by 54
Heterocycle-fused lupane triterpenoids inhibit Leishmania donovani amastigotes
Haavikko, R., Nasereddin, A., Sacerdoti‐Sierra, N., Kopelyanskiy, D., Alakurtti, S., Tikka, M., Jaffe, C. L., & Yli‐Kauhaluoma, J. T. (2014) · MedChemComm · doi:10.1039/c3md00282a · Cited by 54
Developing imidazole analogues as potential inhibitor forLeishmania donovanitrypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach
Pandey, R. K., Sharma, D., Bhatt, T. K., Sundar, S., & Prajapati, V. K. (2015) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2015.1085904 · Cited by 54
A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani
Tegazzini, D., Díaz-González, R., Aguilar, F., Peña, I., Presa, J. L., Yardley, V., Martin, J. J., Coterón, J. M., Croft, S. L., & Cantizani, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01781-15 · Cited by 54
An Innovative Field-Applicable Molecular Test to Diagnose Cutaneous Leishmania Viannia spp. Infections
Saldarriaga, Ó. A., Castellanos-González, A., Porrozzi, R., Baldeviano, G. C., Lescano, A. G., Santos, M. B. D. L., Fernández, O. L., Saravia, N. G., Costa, E. M., Melby, P. C., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004638 · Cited by 54
Scorpion incidents, misidentification cases and possible implications for the final interpretation of results
Lourenço, W. R. (2016) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1186/s40409-016-0075-6 · Cited by 55
Far beyond Phagocytosis: Phagocyte-Derived Extracellular Traps Act Efficiently against Protozoan ParasitesIn VitroandIn Vivo
Silva, L. M. R., Muñoz-Caro, T., Burgos, R. A., Hidalgo, M. A., Taubert, A., & Hermosilla, C. R. (2016) · Mediators of Inflammation · doi:10.1155/2016/5898074 · Cited by 54
Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response
Brettmann, E. A., Shaik, J. S., Zangger, H., Lye, L., Kuhlmann, F., Akopyants, N. S., Oschwald, D. M., Owens, K. L., Hickerson, S. M., Ronet, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615085113 · Cited by 54
Spatial and temporal distribution of American cutaneous leishmaniasis in Acre state, Brazil
Melchior, L. A. K., Brilhante, A. F., & Neto, F. C. (2017) · Infectious Diseases of Poverty · doi:10.1186/s40249-017-0311-5 · Cited by 54
Countervailing, time-dependent effects on host autophagy promote intracellular survival of Leishmania
Thomas, S. A., Nandan, D., Kass, J., & Reiner, N. E. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.808675 · Cited by 54
RIPK1–RIPK3–MLKL-Associated Necroptosis Drives Leishmania infantum Killing in Neutrophils
Barbosa, L. A., Fiuza, P. P., Borges, L. J., Rolim, F. A., Andrade, M. B., Luz, N. F., Carvalho, G. Q., Lima, J. B., de Almeida, R. P., Chan, F. K., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01818 · Cited by 56
A complete Leishmania donovani reference genome identifies novel genetic variations associated with virulence
Lypaczewski, P., Hoshizaki, J., Zhang, W., McCall, L., Torcivia-Rodriguez, J., Simonyan, V. V., Kaur, A., Dewar, K., & Matlashewski, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-34812-x · Cited by 54
Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran
Aflatoonian, M. R., Sharifi, I., Aflatoonian, B., Bamorovat, M., Heshmatkhah, A., Babaei, Z., Almani, P. G. N., Mohammadi, M. A., Salarkia, E., Afshar, A. A., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007423 · Cited by 54
An overview of leishmanization experience: A successful control measure and a tool to evaluate candidate vaccines
Mohebali, M., Nadim, A., & Khamesipour, A. (2019) · Acta Tropica · doi:10.1016/j.actatropica.2019.105173 · Cited by 54
Berberine-Loaded Liposomes for the Treatment of Leishmania infantum-Infected BALB/c Mice
Calvo, A., Moreno, E., Larrea, E., Sanmartín, C., Irache, J. M., & Espuelas, S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090858 · Cited by 54
Kala-azar elimination in a highly-endemic district of Bihar, India: A success story
Kumar, V., Mandal, R., Das, S., Kesari, S., Dinesh, D. S., Pandey, K., Das, V. R., Topno, R. K., Sharma, M. P., Dasgupta, R. K., et al. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008254 · Cited by 53
Emerging and Re-emerging Infectious Diseases in the WHO Eastern Mediterranean Region, 2001-2018
Mostafavi, E., Ghasemian, A., Abubakar, A., Mahani, S. A. N., Rawaf, S., Salehi-Vaziri, ‪., Gouya, M. M., Nguyen, T. M. N., Awaidy, S. T. A., Ariqi, L. A., et al. (2021) · International Journal of Health Policy and Management · doi:10.34172/ijhpm.2021.13 · Cited by 53
Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development
Volpedo, G., Pacheco‐Fernández, T., Bhattacharya, P., Oljuskin, T., Dey, R., Gannavaram, S., Satoskar, A. R., & Nakhasi, H. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.748325 · Cited by 57
Antimony transport mechanisms in resistant leishmania parasites
Frézard, F., do Monte‐Neto, R. L., & dos Reis, P. G. (2014) · Biophysical Reviews · doi:10.1007/s12551-013-0134-y · Cited by 53
Leishmania tarentolae molecular signatures in a 300 hundred-years-old human Brazilian mummy
Novo, S. P. C., Leles, D., Bianucci, R., & de Araújo, A. J. G. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-0666-z · Cited by 53
Dynamic Relations between Incidence of Zoonotic Cutaneous Leishmaniasis and Climatic Factors in Golestan Province, Iran.
Shirzadi, M. R., Mollalo, A., & Yaghoobi‐Ershadi, M. R. (2015) · PubMed Central · Cited by 53
Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters
Fiuza, J. A., Dey, R., Davenport, D., Abdeladhim, M., Meneses, C., Oliveira, F., Kamhawi, S., Valenzuela, J. G., Gannavaram, S., & Nakhasi, H. L. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004322 · Cited by 53
Anti-parasitic Peptides from Arthropods and their Application in Drug Therapy
Lacerda, A. F., Pelegrini, P. B., de Oliveira, D. M., de Vasconcelos, É. A. R., & Grossi‐de‐Sá, M. F. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00091 · Cited by 53
Antileishmanial and Immunomodulatory Activity of Allium sativum (Garlic)
Foroutan, M., Tappeh, K. H., & Khademvatan, S. (2015) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587215623126 · Cited by 53
Allicin Induces Calcium and Mitochondrial Dysregulation Causing Necrotic Death in Leishmania
Corral, M. J., Benito‐Peña, E., Jiménez-Antón, M. D., Cuevas, L., Moreno‐Bondi, M. C., & Alunda, J. M. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004525 · Cited by 53
Ecological Niche Modeling for the Prediction of the Geographic Distribution of Cutaneous Leishmaniasis in Tunisia
Chalghaf, B., Chlif, S., Mayala, B. K., Ghawar, W., Bettaieb, J., Harrabi, M., Bénié, G. B., Michael, E., & Salah, A. B. (2016) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0345 · Cited by 53
In Vitro Effects of the Neolignan 2,3‐Dihydrobenzofuran Against Leishmania Amazonensis
Oliveira, L. G. D. C., Brito, L. M., Alves, M. M. D. M., Amorim, L. V., Sobrinho‐Júnior, E. P. C., de Carvalho, C. E. S., Rodrigues, K. A. D. F., Arcanjo, D. D. R., Citó, A. M. D. G. L., & Carvalho, F. A. D. A. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12639 · Cited by 53
Antileishmanial effect of new indeno-1,5-naphthyridines, selective inhibitors of Leishmania infantum type IB DNA topoisomerase
Tejería, A., Pérez‐Pertejo, Y., Reguera, R. M., Balaña‐Fouce, R., Alonso, C., Fuertes, M., González, M., Rubiales, G., & Palácios, F. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.017 · Cited by 53
The Lutzomyia longipalpis complex: a brief natural history of aggregation-sex pheromone communication
Spiegel, C., Dias, D. B. D. S., Araki, A. S., Hamilton, J. G., Brazil, R., & Jones, T. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1866-x · Cited by 53
Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis
Margaroni, M., Agallou, M., Athanasiou, E., Kammona, O., Kiparissides, C. A., Gaitanaki, C., & Karagouni, E. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s141069 · Cited by 53
Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria
Eddaikra, N., Aït-Oudhia, K., Kherrachi, I., Oury, B., Moulti-Mati, F., Benikhlef, R., Harrat, Z., & Séréno, D. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006310 · Cited by 53
Leishmanicidal activity of α-bisabolol from Tunisian chamomile essential oil
Hajaji, S., Sifaoui, I., López‐Arencibia, A., Reyes-Batllé, M., Jiménez, I. A., Bazzocchi, I. L., Valladares, B., Akkari, H., Lorenzo‐Morales, J., & Piñero, J. E. (2018) · Parasitology Research · doi:10.1007/s00436-018-5975-7 · Cited by 53
Molecular Aspects of Dendritic Cell Activation in Leishmaniasis: An Immunobiological View
Tibúrcio, R., Nunes, S., Nunes, I. V., Ampuero, M. R., Bonyek-Silva, Í., Lima, R., Tavares, N. M., & Brodskyn, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00227 · Cited by 53
Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects
Mostafavi, M., Sharifi, I., Farajzadeh, S., Khazaeli, P., Sharifi, H. P., Pourseyedi, E., Kakooei, S., Bamorovat, M., Keyhani, A., Parizi, M. H., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108942 · Cited by 53
Cutaneous leishmaniasis in Syria: A review of available data during the war years: 2011–2018
Muhjazi, G., Gabrielli, A. F., Ruiz-Postigo, J. A., Atta, H., Osman, M., Bashour, H. N., Tawil, A., Husseiny, H., Allahham, R., & Allan, R. J. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007827 · Cited by 53
Parasites
Theel, E. S., & Pritt, B. S. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0013-2015 · Cited by 61
Seroprevalence and risk factors associated with exposure to Leishmania infantum in dogs, in an endemic Mediterranean region
Rombolà, P., Barlozzari, G., Carvelli, A., Scarpulla, M., Iacoponi, F., & Macrì, G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244923 · Cited by 52
AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial
Burza, S., Mahajan, R., Kazmi, S., Alexander, N. D. E., Kumar, D., Kumar, V., Lasry, E., Harshana, A., Pereira, A. D. L., Das, P. K., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac127 · Cited by 52
“Visceral leishmaniasis (VL) caused by the parasite Leishmania donovani is endemic to Bihar, a populous state of 125 million people in North India, which has, until very recently, carried an estimated 40% of the global VL burden [2].”
Background
Canine leishmaniasis in the Americas: etiology, distribution, and clinical and zoonotic importance
Dantas‐Torres, F. (2024) · Parasites & Vectors · doi:10.1186/s13071-024-06282-w · Cited by 52
“…] , B o l i v i a [ 94 ] , B r a z i l [ 101 ] , C a n a d a [ 102 ] d , C o l o m b i a [ 15 ] , C o s t a R i c a [ 26 ] , E l S a l v a d o r [ 26 ] , F r e n c h G u i a n a [ 16 ] , G u a t e m a l a [ 26 ] , H o n d u r a s [ 26 ] , M e x i c o [ 26 ] , N i c a r a g u a [ 26 ] , P a n a m…”
BackgroundResultInfluential
Advances in Leishmania Vaccines: Current Development and Future Prospects
Ayala, A., Llanes, A., Lleonart, R., & Restrepo, C. M. (2024) · Pathogens · doi:10.3390/pathogens13090812 · Cited by 52
“Furthermore, an estimated 700,000 new cases of VL and more than 1 million new cases of CL are reported each year [10].”
Background
A novel non-amplification assay for the detection of Leishmania spp. in clinical samples using gold nanoparticles
Ανδρεάδου, Μ., Liandris, E., Gazouli, M., Τaka, S., Αντωνίου, Μ., Théodoropoulos, G., Tachtsidis, I., Goutas, N., Vlachodimitropoulos, D. G., Kasampalidis, I. N., et al. (2013) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2013.10.011 · Cited by 52
SPR analysis of the interaction between a recombinant protein of unknown function in Leishmania infantum immobilised on dendrimers and antibodies of the visceral leishmaniasis: A potential use in immunodiagnosis
Souto, D. E. P., Fonseca, A. M., Barragan, J. T. C., Luz, R. D. C. S., de Andrade, H. M., Damos, F. S., & Kubota, L. T. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.03.034 · Cited by 52
Identification of Leishmania by Matrix-Assisted Laser Desorption Ionization–Time of Flight (MALDI-TOF) Mass Spectrometry Using a Free Web-Based Application and a Dedicated Mass-Spectral Library
Lachaud, L., Fernández‐Arévalo, A., Normand, A., Lami, P., Nabet, C., Donnadieu, J. L., Piarroux, M., Djenad, F., Cassagne, C., Ravel, C., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00845-17 · Cited by 52
Clinical and immunopathological findings during long term follow-up in Leishmania infantum experimentally infected dogs
Abbehusen, M. M. C., Almeida, V. D. A., Solcà, M. D. S., Pereira, L. D. S., Costa, D. J., Gil-Santana, L., Bozza, P. T., Fraga, D. B. M., Veras, P. S. T., dos‐Santos, W. L. C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15651-8 · Cited by 52
Fatores ambientais associados à ocorrência de leishmaniose visceral canina em uma área de recente introdução da doença no Estado do Rio de Janeiro, Brasil
Abrantes, T. R., Werneck, G. L., de Almeida, A. S., & Figueiredo, F. B. (2018) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00021117 · Cited by 52
Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis
Thomas, M. G., Rycker, M. D., Ajakane, M., Albrecht, S. J. ‐., Álvarez-Pedraglio, A. I., Böesche, M., Brand, S. L., Campbell, L. A., Cantizani-Perez, J., Cleghorn, L. A. T., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01218 · Cited by 52
Need for sustainable approaches in antileishmanial drug discovery
Hendrickx, S., Caljon, G., & Maes, L. J. R. M. (2019) · Parasitology Research · doi:10.1007/s00436-019-06443-2 · Cited by 52
Meta-taxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State India
Lappan, R. J., Classon, C., Kumar, S. B., Singh, O. P., de Almeida, R. V., Chakravarty, J., Kumari, P., Kansal, S., Sundar, S., & Blackwell, J. M. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007444 · Cited by 52
Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: real-time PCR assay plus
Mehrizi, T. Z., Khamesipour, A., Ardestani, M. S., Shahmabadi, H. E., Hoseini, M. H. M., Mosaffa, N., & Ramezani, A. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s220410 · Cited by 52
Human genetics of leishmania infections
Blackwell, J. M., Fakiola, M., & Castellucci, L. C. (2020) · Human Genetics · doi:10.1007/s00439-020-02130-w · Cited by 52
The potential role and apoptotic profile of three medicinal plant extracts on Leishmania tropica by MTT assay, macrophage model and flow cytometry analysis
Ilaghi, M., Sharifi, I., Sharififar, F., Sharifi, F., Oliaee, R. T., Babaei, Z., Meymandi, M. S., Keyhani, A., & Bamorovat, M. (2021) · Parasite Epidemiology and Control · doi:10.1016/j.parepi.2021.e00201 · Cited by 52
Paromomycin-loaded mannosylated chitosan nanoparticles: Synthesis, characterization and targeted drug delivery against leishmaniasis
Esfandiari, F., Motazedian, M. H., Asgari, Q., Morowvat, M. H., Molaei, M., & Heli, H. (2019) · Acta Tropica · doi:10.1016/j.actatropica.2019.105072 · Cited by 52
An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major
Iniguez, E., Schocker, N. S., Subramaniam, K. S., Portillo, S., Montoya, A. L., Al-Salem, W. S., Torres, C. L., Rodriguez, F., Moreira, O. C., Acosta-Serrano, Á., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006039 · Cited by 51
Viruses of protozoan parasites and viral therapy: Is the time now right?
Barrow, P., Dujardin, J., Fasel, N. J., Greenwood, A. D., Osterrieder, N., Lomonossoff, G. P., Fiori, P. L., Atterbury, R. J., Rossi, M., & Lalle, M. (2020) · Virology Journal · doi:10.1186/s12985-020-01410-1 · Cited by 50
Novel coumarin-isatin hybrids as potent antileishmanial agents: Synthesis, in silico and in vitro evaluations
Khatoon, S., Aroosh, A., Islam, A., Kalsoom, S., Ahmad, F., Hameed, S., Abbasi, S. W., Yasinzai, M., & Naseer, M. M. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104816 · Cited by 51
Development of a Novel Formulation with Hypericin To Treat Cutaneous Leishmaniasis Based on Photodynamic Therapy inIn VitroandIn VivoStudies
Montoya, A., Daza, A., Muñoz, D. L., Ríos, K., Taylor, V. M., Cedeño, D. L., Vélez, I. D., Echeverri, F., & Robledo, S. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00545-15 · Cited by 51
The role of modern drug discovery in the fight against neglected and tropical diseases
Burrows, J. N., Elliott, R. L., Kaneko, T., Mowbray, C. E., & Waterson, D. (2014) · MedChemComm · doi:10.1039/c4md00011k · Cited by 50

Authors: Alvar, J., Vélez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., Boer, M. D., & the WHO Leishmaniasis Control Team
Affiliations: World Health Organization (CH)
Universidad de Antioquia (CO)
Centers for Disease Control and Prevention (US)
Instituto de Salud Carlos III (ES)
Corresponding author: Alvar, Jorge
ORCID: Alvar, Jorge
Vélez, Iván D.
Bern, Caryn
Cano, Jorge
Boer, Margriet den
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2012-05-31
Volume: 7
Issue: 5
Pages: e35671
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0035671
PMC: PMC3365071
OpenAlex: W2107915297
Cited by: 5,141
References: 51
Citations by year: 2026: 177 · 2025: 229 · 2024: 257 · 2023: 305 · 2022: 358 · 2021: 456 · 2020: 468 · 2019: 458 · 2018: 515 · 2017: 440 · 2016: 465 · 2015: 361 · 2014: 404 · 2013: 200 · 2012: 38
FWCI: 310.03
Type: journal article
Language: en
Open access: gold
doi.org
Licence: public-domain
creativecommons.org/publicdomain/zero/1.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, public-domain)
Europe PMC (PubMed Central) (publishedVersion, public-domain)
PubMed Central (publishedVersion, public-domain)
PubMed (publishedVersion)
LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Figshare (submittedVersion, cc-by)
Funders: Sanofi
Universidad de Medellín
Pan American Health Organization
Agencia Española de Cooperación Internacional para el Desarrollo
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
Health Sciences › Medicine › Infectious Diseases › Brucella: diagnosis, epidemiology, treatment
Keywords: leishmaniasis, visceral leishmaniasis, cutaneous leishmaniasis, leishmaniasis incidence, country profile, leishmaniasis control, leishmaniasis treatment, access to medicines, neglected tropical diseases, case data
MeSH terms: Female, Geography, Humans, Leishmaniasis, Male, Time Factors, World Health Organization, Internationality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Leishmaniasis Worldwide and Global Estimates of Its Incidence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks